Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 68 of 114

  1. NP101

    Teva Pharma GmbH

    Migraine Disorders

    phase 3 small molecule completed

    2 trials

  2. NP101 Sumatriptan Iontophoretic Transdermal Patch

    Teva Pharma GmbH

    Migraine Disorders

    phase 3 small molecule completed

    2 trials

  3. NPC-11 for intravenous or oral administration.

    Belpharma s.a.

    Apnea of Prematurity

    phase 3 small molecule completed

    1 trial

  4. NPSP558

    Takeda

    Hypoparathyroidism

    phase 3 small molecule completed

    3 trials

  5. NRG-GY019

    Ningbo Cancer Hospital

    low-grade serous carcinoma of the ovary or peritoneum

    phase 3 small molecule active

    1 trial

  6. NT-PPR-EU002

    Merz Therapeutics GmbH

    Moderate to Severe Platysma Prominence

    phase 3 small molecule active

    1 trial

  7. NTLA-2001

    Regeneron UK Limited

    Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

    phase 3 mab active

    1 trial

  8. NUBEQA film-coated tablets for Localised Very High-Risk Cancer of the Prostate

    Ningbo Cancer Hospital

    Localised Very High-Risk Cancer of the Prostate

    phase 3 small molecule active

    1 trial

  9. NUC01, Placebo to NUC01

    Dr. Falk Pharma GmbH

    primary sclerosing cholangitis (PSC)

    phase 3 small molecule active

    1 trial

  10. NUT01

    Dr. Falk Pharma GmbH

    Primary Sclerosing Cholangitis (PSC)

    phase 3 small molecule active

    1 trial

  11. NW-3509/023/III/2024

    Lacuna Pharma Pty Ltd

    treatment-resistant schizophrenia (TRS)

    phase 3 small molecule active

    1 trial

  12. NX-5948

    Nurix Therapeutics

    B-cell Lymphoma

    phase 3 small molecule active

    2 trials

  13. NXPLEVE/24/P3-6

    NEURAXPHARM AUSTRALIA PTY LIMITED

    Refractory Partial Onset Epilepsy

    phase 3 small molecule active

    1 trial

  14. NXY-059

    AstraZeneca

    Cerebral Stroke

    phase 3 small molecule completed

    1 trial

  15. NaCl 0.9%, DEXAMETHASONE

    Pari Pharma GmbH

    Cervicobrachial Neuralgia

    phase 3 small molecule active

    1 trial

  16. Nab-paclitaxel 80 mg/m^2

    CORCEPT THERAPEUTICS INC

    Ovarian Neoplasm

    phase 3 small molecule active

    1 trial

  17. Nabilone

    BRIGHT MINDS BIOSCIENCES INC.

    Alzheimer Disease

    phase 3 small molecule active

    1 trial

  18. Nabilone

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    phase 3 small molecule completed

    1 trial

  19. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    Spasticity With Multiple Sclerosis

    phase 3 small molecule terminated

    1 trial

  20. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    Post-Traumatic Stress Disorder

    phase 3 small molecule terminated

    1 trial

  21. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    Multiple Sclerosis (MS)

    phase 3 small molecule terminated

    1 trial

  22. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    Pain

    phase 3 small molecule completed

    3 trials

  23. Nabiximols

    Jazz Pharmaceuticals Ireland Limited

    Spasticity in Participants With Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  24. Nadroparin, long term

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    phase 3 small molecule active

    1 trial

  25. Nalbuphine ER Tablets

    Trevi Therapeutics

    Prurigo Nodularis

    phase 3 small molecule completed

    1 trial

  26. Nalfurafine Hydrochloride

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Uremic Pruritus

    phase 3 small molecule active

    1 trial

  27. Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Alcoholism

    phase 3 small molecule completed

    1 trial

  28. Namodenoson

    Can-Fite BioPharma

    Hepatocellular Carcinoma

    phase 3 small molecule active

    1 trial

  29. Nano-crystalline Megestrol Acetate Oral Suspension

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Extensive-stage Small Cell Lung Cancer (ES-SCLC)

    phase 3 small molecule active

    1 trial

  30. Nanocovax

    Biotech Pharmaceutical Co.,

    SARS-CoV-2 Infection

    phase 3 mab completed

    1 trial

  31. Napabucasin

    Sumitomo Pharma (Suzhou) Co.,

    Carcinoma, Pancreatic Ductal

    phase 3 small molecule completed

    1 trial

  32. Natriumklorid Braun /ml spädningsvätska för p... for Allergisk Rinit

    The George Institute

    Allergisk Rinit

    phase 3 small molecule active

    1 trial

  33. Necitumumab

    Eli Lilly and Company

    Non Small Cell Lung Cancer

    phase 3 mab completed

    1 trial

  34. Nedaplatin

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 3 small molecule completed

    1 trial

  35. Nemolizumab

    Galderma Australia Pty Ltd

    Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  36. Nemolizumab

    Galderma Australia Pty Ltd

    Prurigo Nodularis

    phase 3 small molecule active

    1 trial

  37. Nemtabrutinib

    Merck KGaA, Darmstadt, Germany

    Chronic Lymphocytic Leukemia

    phase 3 small molecule active

    1 trial

  38. Neugranin

    Teva Pharma GmbH

    Chemotherapy-induced Neutropenia

    phase 3 mab completed

    1 trial

  39. Neuraceq 300 MBq/mL solution for injection

    Fondazione Telethon ETS

    cardiac amyloidosis

    phase 3 small molecule active

    1 trial

  40. New thickened formula

    United Therapeutics Europe Ltd

    Gastroesophageal Reflux

    phase 3 other completed

    1 trial

  41. Newnorm

    Maze Therapeutics

    Human Normal Immunoglobulin

    phase 3 small molecule active

    1 trial

  42. Niclosamide

    United Therapeutics Europe Ltd

    Covid19

    phase 3 small molecule completed

    1 trial

  43. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 3 small molecule completed

    2 trials

  44. Nicotine patch

    Jasper Therapeutics

    Nicotine Dependence

    phase 3 small molecule active

    1 trial

  45. Nicotine polacrilex, Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 3 small molecule completed

    1 trial

  46. Nicotinomide

    United Therapeutics Europe Ltd

    Glaucoma, Open-Angle

    phase 3 small molecule active

    1 trial

  47. Nifedipine (Adalat, BAYA1040)

    Bayer HealthCare AG

    Hypertension

    phase 3 small molecule completed

    1 trial

  48. Nilotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Myeloid Leukemia, Chronic Phase

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.